Eric Olson
Overview
Explore the profile of Eric Olson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hunting J, Price S, Faucheux A, Olson E, Elko C, Quattlebaum A, et al.
Immunotherapy
. 2025 Jan;
17(1):19-24.
PMID: 39844686
Background: Prior research indicates a connection between immune-related adverse events (irAEs) and improved progression-free survival (PFS) and overall survival (OS) in non-small cell lung cancer. However, limited data exists for...
2.
Hunting J, Deyo L, Olson E, Faucheux A, Price S, Lycan Jr T
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272903
Background: Immune checkpoint inhibitors (ICIs) have become common lines of therapy for genitourinary cancers (GUcs). Given their widespread use, understanding the risk factors, comparative profiles, and timing of immune-related adverse...
3.
Hunting J, Faucheux A, Price S, Elko C, Quattlebaum A, Bloomer C, et al.
Immunotherapy
. 2024 Jan;
16(6):381-390.
PMID: 38197144
Neurological adverse events (NAEs) are infrequent immune checkpoint inhibitor (ICI) outcomes poorly characterized in extant research, complicating their clinical management. This study characterized the frequency, severity, patterning and timing of...
4.
Siles N, Schuler M, Maguire C, Amengor D, Nguyen A, Wilen R, et al.
medRxiv
. 2023 Dec;
PMID: 38106077
Background: Understanding the kinetics and longevity of antibody responses to SARS-CoV-2 is critical to informing strategies toward reducing Coronavirus disease 2019 (COVID-19) reinfections, and improving vaccination and therapy approaches. Methods:...
5.
Rishi M, Cheng J, Strang A, Sexton-Radek K, Ganguly G, Licis A, et al.
J Clin Sleep Med
. 2023 Oct;
20(1):121-125.
PMID: 37904574
Citation: Rishi MA, Cheng JY, Strang AR, et al. Permanent standard time is the optimal choice for health and safety: an American Academy of Sleep Medicine position statement. . 2024;20(1):121-125.
6.
Gao H, Jorgensen R, Raghunath R, Chandra S, Othman A, Olson E, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982527
Wheat allergies are potentially life-threatening and, therefore, have become a major health concern at the global level. It is largely unknown at present whether genetic variation in allergenicity potential exists...
7.
Faucheux A, Olson E, Lantz J, Roberts N, Aggarwal V, Newman I, et al.
Cureus
. 2023 Mar;
15(2):e34683.
PMID: 36909081
Background Despite being a groundbreaking cancer therapy, immune checkpoint inhibitors (ICI) can lead to potentially life-threatening toxicity with checkpoint inhibitor pneumonitis (CIP). While treatable, it is easy for clinicians to...
8.
Halder J, Gill H, Zhang J, ALtameemi R, Olson E, Turnipseed B, et al.
Plant Genome
. 2023 Jan;
16(1):e20300.
PMID: 36636831
A better understanding of the genetic control of spike and kernel traits that have higher heritability can help in the development of high-yielding wheat varieties. Here, we identified the marker-trait...
9.
Bazzi S, Maguire C, Holay N, Geltman J, Hurley K, DiPasquale C, et al.
Mult Scler Relat Disord
. 2022 Oct;
68:104195.
PMID: 36223705
Background And Objectives: During the COVID-19 pandemic, B cell depleting therapies pose a clinical concern for patients with neuroimmune conditions, as patients may not mount a sufficient immune response to...
10.
Jorgensen R, Raghunath R, Gao H, Olson E, Ng P, Gangur V
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35742949
Wheat allergies are potentially life-threatening because of the high risk of anaphylaxis. Wheats belong to four genotypes represented in thousands of lines and varieties. Monitoring changes to wheat allergens is...